ISSN 3060-4745 Open Access · Peer Reviewed
PDF
ZENODO

Keywords

cardiometabolic syndrome, diabetes, hypertension, obesity, cardiovascular diseases, insulin resistance, dyslipidemia, inflammation, metabolic disorders, prevention, pharmacotherapy

How to Cite

CARDIOMETABOLIC SYNDROME: THE IMPACT OF DIABETES, HYPERTENSION, AND OBESITY ON CARDIOVASCULAR DISEASES. (2025). ACUMEN: INTERNATIONAL JOURNAL OF MULTIDISCIPLINARY RESEARCH, 2(2), 324-328. https://www.universalpublishings.com/index.php/aijmr/article/view/10237

Abstract

Cardiometabolic syndrome is a complex pathological condition characterized by the coexistence of diabetes, hypertension, and obesity, significantly increasing the risk of developing cardiovascular diseases. This article analyzes the pathophysiological mechanisms of cardiometabolic syndrome, including insulin resistance, inflammatory processes, and dyslipidemia, and their impact on heart function. Additionally, strategies for disease prevention and treatment, including lifestyle modifications, pharmacological approaches, and current clinical recommendations, are discussed. The research findings highlight the necessity of developing effective preventive and therapeutic measures against cardiometabolic syndrome.

PDF
ZENODO

References

1. Grundy SM, Brewer HB, Cleeman JI, et al. "Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference." Circulation, 2004; 109(3):433-438.

2. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. "The Metabolic Syndrome." The Lancet, 2010; 375(9710):181-183.

3. Reaven GM. "The Role of Insulin Resistance in Human Disease." Diabetes, 1988; 37(12):1595-1607.

4. Kahn R, Buse J, Ferrannini E, Stern M. "The Metabolic Syndrome: Time for a Critical Appraisal." Diabetes Care, 2005; 28(9):2289-2304.

5. World Health Organization (WHO). "Global Report on Diabetes." 2016. Available from: https://www.who.int/publications/i/item/9789241565257

6. American Diabetes Association (ADA). "Standards of Medical Care in Diabetes – 2023." Diabetes Care, 2023; 46(Suppl. 1):S1-S257. Available from: https://diabetesjournals.org/care/issue/46/Supplement_1

7. European Society of Cardiology (ESC). "Guidelines on Cardiovascular Disease Prevention in Clinical Practice." Eur Heart J, 2021; 42(34):3227-3337. Available from: https://www.escardio.org/Guidelines

8. National Cholesterol Education Program (NCEP). "ATP III Guidelines for Metabolic Syndrome." National Heart, Lung, and Blood Institute, 2001. Available from: https://www.nhlbi.nih.gov/files/docs/guidelines/atp3xsum.pdf

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Indexed In · Partners

Trusted by Global Scientific Indexing Services

JUSR is indexed and recognized by leading international databases and research integrity organizations.